Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 9 citing articles:

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs
Sara Janowska, Serhii Holota, Roman Lesyk, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 346-346
Open Access | Times Cited: 7
Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023)
Neha Bhatia, Suresh Thareja
Bioorganic Chemistry (2024) Vol. 151, pp. 107607-107607
Closed Access | Times Cited: 7
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer
Gloria Ana, Azizah M. Malebari, Sara Noorani, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 118-118
Open Access
Design and Synthesis of Newly Synthesized Acrylamide Derivatives as Potential Chemotherapeutic Agents against MCF-7 Breast Cancer Cell Line Lodged on PEGylated Bilosomal Nano-Vesicles for Improving Cytotoxic Activity
Islam Zaki, Reham A. I. Abou‐Elkhair, Ali H. Abu Almaaty, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1021-1021
Open Access | Times Cited: 23
Novel imidazole derivatives as potential aromatase and monoamine oxidase-B inhibitors against breast cancer
Derya Osmani̇ye, Serkan Levent, Begüm Nurpelin Sağlık, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 16, pp. 7442-7451
Closed Access | Times Cited: 12
Discovery of Novel Tris-1,2,3-Triazole-Based Hybrids as Vegfr2 Inhibitors with Potent Anti-Proliferative and Cytotoxicity Through Apoptosis Induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
(2024)
Closed Access
Special Issue “Anticancer Drugs 2021”
Mary J. Meegan, Niamh M. O’Boyle
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 479-479
Open Access | Times Cited: 3
Design and Synthesis of Imidazole Derivatives as Anticancer Agents and Potential Aromatase Inhibitors
Hayrani Eren Bostancı, Ulviye Acar Çevik
Cumhuriyet Science Journal (2022) Vol. 43, Iss. 4, pp. 590-593
Open Access
Page 1

Scroll to top